维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Horlings HM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Micro RNA sequence and expression analysis in breast tumors by deep sequencing显示文摘	Farazi TA Horlings HM Ten Hoeve JJ	2011	Cancer Res2011，71，13：	1
2	A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer 显示文摘	Berns K Horlings HM Hennessy BT	2007	Cancer Cell2007，12，39：	1
3	A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer 显示文摘	Berns K Horlings HM Hennessy BT	2007	Cancer Cell2007，12，4：	1
4	Mucinousand neumendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type 显示文摘	Weigelt B Geyer FC Horlings HM	2009	Mod Pathol2009，22，11：	1
5	A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumabresistance in breast cancer显示文摘	Berns K Horlings HM Hennessy BT		0，，04：	1
6	EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer 显示文摘	Pietersen AM Horlings HM Hauptmann M	2008	Breast Cancer Res2008，10，6：	1
7	High preva- lence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites显示文摘	Kraan W Horlings HM van Keimpema M	2013	Blood Cancer J2013，3，3：	1
8	A functional genetic approach identifies the PI3K pathway as a majoy determinant of trastuzumab resistance in breast cancer显示文摘	Berns K Horlings HM Hennessy BT		0，，04：	1
9	A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer显示文摘	Berns K Horlings HM Hennessy BT		0，，：	1
10	A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer 显示文摘	Berns K Horlings HM Hennessy BT	2007	Cancer CEU2007，12，：	1
11	High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites显示文摘	Kraan W Horlings HM van Keimpema M	2013	Blood Cancer J2013，3，：	1
12	A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer显示文摘	Berns K Horlings HM Hennessy BT	2007	Cancer Cell2007，12，4：	1
13	EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer显示文摘	Pietersen AM Horlings HM Hauptmann M	2008	Breast Cancer Res2008，10，6：	1
14	A function- al genetic approach identifies the PI3K pathway as a major deter- minant of trastuzumab resistance in breast cancer 显示文摘	BERNS K HORLINGS HM HENNESSY aT	2007	Cancer Cell2007，12，4：	1
15	BRCA1 - mutated and basal - like breast canc- ers have similar aCGH profiles and a high inci- dence of protein truncating TP53 mutations显示文摘	Holstege H Horlings HM Velds A	2010	BMC Cancer2010，10，：	1
16	Refinement of breast cancer classification by molecular characterization of histological special types显示文摘	Weigelt B Horlings HM Kreike B	2008	J Pathol2008，216，2：	1
17	A functional genet- ic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer显示文摘	Berns K Horlings HM Hennessy BT	2007	Cancer Cell2007，12，4：	1
18	A functional genetic approach identifies the P13K pathway as a major determinant of trastuzumab resistance in breast cancer显示文摘	Berns K Horlings HM Hennessy BT		0，，04：	1
19	EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer显示文摘	Pietersen AM Horlings HM Hauptmann M		0，，06：	1
20	Integrative molecu- lar profiling of triple negative breast cancers identifies amplieon drivers and potential therapeutic targets 显示文摘	Turner N Lambros MB Horlings HM	2010	Oneogene2010，29，14：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示